Skip to main content
Premium Trial:

Request an Annual Quote

PamGene and Jerini Peptide Technologies Jointly Offer Products

NEW YORK, June 22 (GenomeWeb News) - PamGene International and Jerini Peptide Technologies will jointly offer their microarray and peptide products for kinase studies, the companies said today.


Under the agreement, PamGene and Jerini will offer PamGene's 96-well microarray platform and Jerini's kinase peptide substrates.


Jerini Peptide Technologies of Berlin, a division of Jerini, provides peptide-based services and products. PamGene International, based in 's-Hertogenbosch, the Netherlands, offers three-dimensional microarray technology.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.